Pediatric fever treatment
This article was originally published in The Tan Sheet
Executive SummaryAlternating acetaminophen (12.5 mg/kg) and ibuprofen (5 mg/kg) in young children is more effective for reducing fever than mono-therapy, a randomized, parallel-group trial in the February Archives of Pediatrics & Adolescent Medicine finds. The study was conducted in 464 children aged 6-36 months, with a follow-up period of 10 days. Children who received alternating doses every four hours for three days also received a lower mean number of doses per child in days 1-3, required 22.6% fewer doses from day 1-2 and had fewer fever recurrences on days five and ten, Michael Sarrell, MD, et al., Tel Aviv University, report. Difference in fever reduction between acetaminophen and ibuprofen groups was not statistically significant. Participants "may have been more seriously ill than most of the children who receive over-the-counter antipyretics" since they were recruited at presentation for treatment, the authors note...
You may also be interested in...
Number one ask is for congressional pressure to centralize rare disease expertise at the agency, but advocates also are preparing legislation that would mandate the new center.
FDA’s food, dietary supplement and cosmetics division seeks funding to support its artificial intelligence capabilities, including post-market surveillance and speedy interventions in instances where safety issues arise. Also of note, the agency cites UV filters’ effects on the skin microbiome as a research priority in its fiscal 2021 budget justification to Congress.
Catering to patients can help make clinical trials more accessible and useful, presenters argued at a recent conference.